| Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause |
26 |
| The prevalence of urinary incontinence |
19 |
| The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause |
13 |
| Fibroid management in premenopausal women |
13 |
| The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis |
11 |
| Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials |
10 |
| Progesterone for the prevention and treatment of osteoporosis in women |
8 |
| Ovarian aging: an ongoing prospective community-based cohort study in middle-aged Chinese women |
8 |
| Global Consensus Position Statement on the Use of Testosterone Therapy for Women |
8 |
| Innovative approaches to cervical cancer screening in low- and middle-income countries |
8 |
| Endometriosis: seeking optimal management in women approaching menopause |
7 |
| Sexual well-being after menopause: An International Menopause Society White Paper |
7 |
| Mediterranean diet is associated with bone mineral density and muscle mass in postmenopausal women |
7 |
| Experiences of menopause, self-management strategies for menopausal symptoms and perceptions of health care among immigrant women: a systematic review |
7 |
| Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study |
7 |
| Sexual quality of life in men and women after cancer |
7 |
| Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines |
7 |
| The history of natural progesterone, the never-ending story |
6 |
| Vaginal atrophy across the menopausal age: results from the ANGEL study |
6 |
| Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial |
6 |
| Association of VDR and OPG gene polymorphism with osteoporosis risk in Chinese postmenopausal women |
6 |
| Predictors of malignancy in endometrial polyps: study of 421 women with postmenopausal bleeding |
6 |
| Rationale and design for fractional microablative CO2 laser versus photothermal non-ablative erbium:YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial |
6 |
| The effect of vitamin D2 supplementation on muscle strength in early postmenopausal women: a randomized, double-blind, placebo-controlled trial |
6 |
| Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators |
5 |
| Pelvic floor muscle function and EMG in nulliparous women of different ages: a cross-sectional study |
5 |
| Sexuality in premature ovarian insufficiency |
5 |
| Progesterone, progestins and the breast in menopause treatment |
5 |
| Progesterone for treatment of symptomatic menopausal women |
5 |
| Endometrial pathology in recurrent postmenopausal bleeding: observational study of 385 women |
5 |
| The impact of micronized progesterone on breast cancer risk: a systematic review |
5 |
| Female hormonal factors and osteoarthritis of the knee, hip and hand: a narrative review |
5 |
| Managing vasomotor symptoms in women after cancer |
5 |
| Factors related to muscle strength in postmenopausal women aged younger than 65 years with normal vitamin D status |
4 |
| Cause or prevention of breast cancer with estrogens: analysis from tumor biologic data, growth kinetic model and Women's Health Initiative study |
4 |
| Non-clinical studies of progesterone |
4 |
| Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis |
4 |
| Vasomotor symptoms: natural history, physiology, and links with cardiovascular health |
4 |
| Sexual function after cancer: paying the price of survivorship |
4 |
| A comparison of three outcome measures of the impact of vasomotor symptoms on women's lives |
4 |
| Higher intake of dietary n-3 PUFA and lower MUFA are associated with fewer menopausal symptoms |
4 |
| Role of breast density measurement in screening for breast cancer |
4 |
| Royal jelly does not prevent bone loss but improves bone strength in ovariectomized rats |
4 |
| Case report of the first successful cryopreserved ovarian tissue retransplantation in China |
4 |
| Postmenopausal endometriosis: drawing a clearer clinical picture |
4 |
| Benefit-risk profile of black cohosh (isopropanolic Cimicifuga racemosa extract) with and without St John's wort in breast cancer patients |
4 |
| Metabolic syndrome during female midlife: what are the risks? |
3 |
| Sexual dysfunction in perimenopausal women based on a national epidemiological survey in China |
3 |
| Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women |
3 |
| The use and discontinuation of hormone replacement therapy in women in South China |
3 |
